In what is likely one of the largest treatment rollouts in South African history, well over four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction around four years ago. Now, according to a recent study published in the Lancet medical journal, use of dolutegravir in South Africa is associated with more people staying on treatment and higher rates of viral suppression. Elri Voigt unpacks the study findings and assesses progress in the country’s switch to dolutegravir-based HIV treatment.
The scientific evidence that exclusive breastfeeding is best for infants is very strong. Yet, some baby milk formula companies continue to use questionable methods to create demand for their products, thereby undermining breastfeeding. Elsabé Brits explores this and spoke to experts based on a series of articles published in The Lancet.
There is nothing humans can do about the fact that everyone dies eventually, but there may be room to do better when it comes to how some doctors, nurses, and care workers break the news of dying and death; and also how they give practical support to a grieving family. Ufrieda Ho looks at what measures are in place to guide healthcare workers, patients, and their families through this process in health facilities.
Local researchers have welcomed impressive phase III findings for the Russian-made Sputnik V vaccine published this week in the Lancet medical journal. It is the sixth COVID-19 vaccine found to be effective in preliminary data from a phase III randomised controlled trial and the fourth to have phase III findings published in a leading medical journal.